Hans Heemskerk

Phage display screening without repetitious selection rounds

Peter A.C. ’t Hoen, Silvana M.G. Jirka, Bradley R. ten Broeke et al. · Analytical Biochemistry · 2011 · 169 citations · Full text

Point-of-care Testing, Engineering, Phage Pool +22

<i>In vivo</i> comparison of 2′‐<i>O</i>‐methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping

Hans Heemskerk, C.L. de Winter, Sjef J. de Kimpe et al. · The Journal of Gene Medicine · 2009 · 169 citations · Full text

Guidelines for Antisense Oligonucleotide Design and Insight Into Splice-modulating Mechanisms

Annemieke Aartsma‐Rus, Laura Van de Vliet, Marscha Hirschi et al. · Molecular Therapy · 2008 · 145 citations · Full text

Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model

Hans Heemskerk, Christa de Winter, Petra van Kuik et al. · Molecular Therapy · 2010 · 137 citations · Full text

Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double‐knockout mice

Maaike van Putten, Margriet Hulsker, Courtney S. Young et al. · The FASEB Journal · 2013 · 113 citations · Full text